Previous studies have shown that FDX1, as a key gene in cuproptosis, is involved in the progression of hepatocellular carcinoma [52] and glioma [53] as well as tumor immunity and drug sensitivity [54]. This evidence concerns the gene FDX1 and neoplasm.